How accurate are physicians in the prediction of patient survival in advanced lung cancer?

Oncologist

Volumn 15, Issue 7, 2010, Pages 782-789

  Clément Duchêne, Christelle ^a   Carnin, Charlotte ^a   Guillemin, Francis ^b   Martinet, Yves ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b INSERM   (France)

Author keywords

Advanced stage non small cell lung cancer; Predictive estimation; Prognostic factors; Quality of life; Survival

Indexed keywords

ADULT; ADVANCED CANCER; ARTICLE; CANCER PATIENT; CANCER STAGING; CANCER SURVIVAL; CONTROLLED STUDY; CORRELATION COEFFICIENT; DIAGNOSTIC ACCURACY; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN TISSUE; LARGE CELL CARCINOMA; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; NEUROENDOCRINE TUMOR; PHYSICIAN; PREDICTION; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RESIDENT; SURVIVAL TIME;

AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; FORECASTING; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHYSICIAN'S ROLE; PROGNOSIS; QUALITY OF LIFE; SURVIVAL ANALYSIS;

EID: 77956105060     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2009-0149     Document Type: Article

References (30)

1. Jemal A, Siegel R, Ward E et al. Cancer statistics, 2006. CA Cancer J Clin 2006;56:106-130.
2. Alberg AJ, Brock MV, Samet JM. Epidemiology of lung cancer: Looking to the future. J Clin Oncol 2005;23:3175-3185.
3. Depierre A, Lagrange JL, Theobald S et al. Summary report of the Standards, Options, and Recommendations for the management of patients with non-small-cell lung carcinoma (2000). Br J Cancer 2003;89(suppl 1):S35-S49.
4. Bunn PA, Thatcher N. Systemic treatment for advanced (stage IIIb/IV) non-small cell lung cancer: More treatment options; more things to consider. Conclusion. The Oncologist 2008;13(suppl 1):37-46.
5. Ramalingam S, Belani C. Systemic chemotherapy for advanced non-small cell lung cancer: Recent advances and future directions. The Oncologist 2008;13(suppl 1):5-13.
6. Quoix E. Prognostic factors in unresectable non-small cell lung cancer. In: Brambilla C, Brambilla E, eds. Lung Tumors: Fundamental Biology and Clinical Management. New York: Marcel Dekker, 1999:583-593.
7. Watine J, Rouzaud P, Charet JC. [Bibliographic analysis of the use of laboratory blood parameters for the prognosis of primary lung cancer.] Ann Bio Clin (Paris) 1999;57:57-68. In French.
8. Schleusener JT, Tazelaar HD, Jung SH et al. Neuroendocrine differentiation is an independent prognostic factor in chemotherapy-treated non-small cell lung carcinoma. Cancer 1996;77:1284-1291.
9. Muers MF, Shevlin P, Brown J. Prognosis in lung cancer: Physicians' opinions compared with outcome and a predictive model. Thorax 1996;51:894-902.
10. Tagigawa N, Segawa Y, Okahara M et al. Prognostic factors for patients with advanced non-small cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation. Lung Cancer 1996;15:67-77.
11. Paesmans M, Sculier JP, Libert P et al. Prognostic factors for survival in advanced non-small cell lung cancer: Univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party. J Clin Oncol 1995;13: 1221-1230.
12. Buccheri G, Ferrigno D. Prognostic value of stage grouping and TNM descriptors in lung cancer. Chest 2000;117:1247-1255.
13. Pedersen LM, Milman N. Prognostic significance of thrombocytosis in patients with primary lung cancer. Eur Respir J 1996;9:1826-1830.
14. Gail MH, Eagan RT, Feld R et al. Prognostic factors in patients with resected stage I non-small cell lung cancer. A report from the Lung Cancer Study Group. Cancer 1984;54:1802-1813.
15. Herndon JE, Fleishman S, Kornblith AB et al. Is quality of life predictive of the survival of patients with advanced nonsmall cell lung carcinoma? Cancer 1999;85:333-340.
16. Viganó A, Bruera E, Jhangri GS et al. Clinical survival predictors in patients with advanced cancer. Arch Intern Med 2000;160:861-868.
17. Paesmans M. [Prognostic factors in lung cancer.] Rev Mal Respir 2005;22: 8S76-8S80.
18. Mountain CF. Revisions in the International System for Staging Lung Cancer. Chest 1997;111:1710-1717.
19. Espinosa E, Feliu J, Zamora P et al. Serum albumin and others prognostic factors related to response and survival in patients with advanced non-small lung cancer. Lung Cancer 1995;12:67-76.
20. Langendijk H, Aaronson NK, De Jonk JM et al. The prognostic impact of quality of life assessed with the EORTC QLQ-C30 in inoperable non-small cell lung carcinoma treated with radiotherapy. Radiother Oncol 2000;55: 19-25.
21. Landis JR, Koch GG. An application of hierarchical kappa-type statistics in the assessment of majority agreement among multiple observers. Biometrics 1977;33:363-374.
22. Brandt HE, Ooms ME, Ribbe MW et al. Predicted survival vs. actual survival in terminally ill noncancer patients in Dutch nursing homes. J Pain Symptom Manage 2006;32:560-566.
23. Christakis NA, Lamont EB. Extent and determinants of error in doctors' prognoses in terminally ill patients: Prospective cohort study. BMJ 2000; 320:469-472.
24. Chow E, Harth T, Hruby G et al. How accurate are physicians' clinical predictions of survival and the available prognostic tools in estimating survival times in terminally ill cancer patients? A systematic review. Clin Oncol (R Coll Radiol) 2001;13:209-218.
25. Moldvay J, Scheid P, Wild P et al. Predictive survival markers in patients with surgically resected non-small cell lung carcinoma. Clin Cancer Res 2000;6:1125-1134.
26. Viganó A, Donaldson N, Higginson IJ et al. Quality of life and survival prediction in terminal cancer patients: A multicenter study. Cancer 2004; 101:1090-1098.
27. Viganó A, Dorgan M, Bruera E et al. The relative accuracy of the clinical estimation of the duration of life for patients with end of life cancer. Cancer 1999;86:170-176.
28. Coates AS, Hr̈ny C, Peterson HF et al. Quality-of-life scores predict outcome in metastatic but not early breast cancer. International Breast Cancer Study Group. J Clin Oncol 2000;18:3768-3774.
29. Gripp S, Moeller S, Bölke E et al. Survival prediction in terminally ill cancer patients by clinical estimates, laboratory tests, and self-rated anxiety and depression. J Clin Oncol 2007;25:3313-3320.
30. Llobera J, Esteva M, Rifà J et al. Terminal cancer. Duration and prediction of survival time. Eur J Cancer 2000;36:2036-2043.